Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
1(20.0%)
Phase 3
1(20.0%)
5Total
N/A(3)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03548311Phase 3Completed

Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

Role: collaborator

NCT02890524Not ApplicableCompleted

Tokushima Night Guard for Recurrent Aphthous Stomatitis

Role: lead

NCT01712802Not ApplicableCompleted

Multicenter Study of Denture Adhesive

Role: collaborator

NCT01910363Phase 2Unknown

Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke

Role: lead

NCT01742728Unknown

Nagasaki and Tokushima

Role: lead

NCT00735228Not ApplicableUnknown

Tight Glycemic Control by Artificial Pancreas

Role: collaborator

All 6 trials loaded